Foster Dykema Cabot & Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.5M | Sell |
30,199
-824
| -3% | -$642K | 1.66% | 21 |
|
|
2025
Q1 | $25.6M | Sell |
31,023
-2,537
| -8% | -$2.1M | 2.06% | 17 |
|
|
2024
Q4 | $25.9M | Sell |
33,560
-9,163
| -21% | -$7.07M | 2.02% | 16 |
|
|
2024
Q3 | $37.9M | Sell |
42,723
-1,016
| -2% | -$900K | 3.18% | 7 |
|
|
2024
Q2 | $39.6M | Sell |
43,739
-212
| -0.5% | -$192K | 3.54% | 6 |
|
|
2024
Q1 | $34.2M | Sell |
43,951
-5,497
| -11% | -$4.28M | 3.18% | 6 |
|
|
2023
Q4 | $28.8M | Buy |
+49,448
| New | +$28.8M | 3.05% | 6 |
|